- Current report filing (8-K)
January 23 2009 - 12:02PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported)
October 22, 2008
CANTEL
MEDICAL CORP.
(Exact name of
registrant as specified in its charter)
Delaware
|
|
001-31337
|
|
22-1760285
|
(State or other
jurisdiction
|
|
(Commission
|
|
(IRS
Identification
|
of
incorporation)
|
|
File Number)
|
|
Number)
|
|
|
|
|
|
150
Clove Road, Little Falls, New Jersey
|
|
07424
|
Address of
principal executive offices)
|
|
(Zip Code)
|
Registrants
telephone number, including area code:
(973) 890-7220
(Former name or
former address, if changed since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 5.02
Departure of Directors of
Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
(b) At a meeting of the Board of Directors
of Cantel Medical Corp. (the Company) held on October 22, 2008, Mr. Darwin
Dornbush, a director of the Company since 1963, indicated that he desired not
to stand for re-election at the next Annual Meeting of Stockholders. Therefore,
the Board did not re-nominate Mr. Dornbush as a director and his term of
office expired at the Annual Meeting of Stockholders held on January 8,
2009.
(e) At the Annual Meeting of Stockholders
held on January 8, 2009, the Companys stockholders approved an amendment
to the Cantel Medical Corp. 2006 Equity Incentive Plan (the Plan) to increase
by 700,000 the number of shares of common stock available for issuance under
the Plan. The additional shares were authorized for issuance pursuant to stock
options and stock appreciation rights.
As amended, the maximum number of shares that may be issued under the
Plan increased from 1,000,000 to 1,700,000 shares, with (i) the
number of shares being authorized for issuance pursuant to stock options and
stock appreciation rights being increased from 500,000 to 1,200,000 and (ii) 500,000
shares remaining authorized for issuance pursuant to restricted stock awards
and performance awards (inclusive of prior awards under the Plan).
2
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
|
CANTEL MEDICAL CORP.
|
|
|
|
|
|
|
|
By:
|
/s/ Andrew A. Krakauer
|
|
|
Andrew A. Krakauer
|
|
|
President
|
|
|
|
Dated: January 22,
2009
|
|
|
3
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024